ACSL4 and breast carcinoma: We have presented evidence here that expression of a lipid metabolic enzyme, ACSL4, inversely correlates with the presence of steroid hormone and growth factor receptors in breast cancer, and as such may be a marker for the highly aggressive QNBC.